SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in IMDX — Insight Molecular Diagnostics Inc.
CIK 1446194
BALA CYNWYD, PA
Position in IMDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$183,985
-$359,397 QoQ
Shares Held
56,093
-22.6% QoQ
Ownership
0.174%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMDX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $220,999,669 across 38 Diagnostics & Research names. IMDX ranks #35 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
240,547 | $45,607,710 | |
| 2 | NTRA |
Natera, Inc.
|
199,638 | $39,925,603 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
64,399 | $31,654,039 | |
| 4 | GRAL |
GRAIL, Inc.
|
304,808 | $15,752,477 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
14,061 | $7,900,735 | |
| 6 | QGEN |
Qiagen N.V.
|
185,900 | $7,443,436 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
42,781 | $7,295,871 | |
| 8 | GH |
Guardant Health, Inc.
|
75,989 | $7,019,103 |
All Filings in IMDX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $183,985 | 56,093 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $543,382 | 72,451 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $35,620 | 11,795 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $137,106 | 44,806 | Shares | Other | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||